11 Most Shorted Stocks to Buy According to Analysts

Page 11 of 11

1. Viking Therapeutics, Inc. (NASDAQ:VKTX)

Viking Therapeutics, Inc. (NASDAQ:VKTX) ranks among the most shorted stocks to buy according to analysts. After the company’s fourth-quarter 2025 earnings report, Raymond James maintained its Strong Buy rating on Viking Therapeutics, Inc. (NASDAQ:VKTX) but cut its price objective from $122 to $118 on February 12. The company highlighted its optimistic outlook for Viking’s oral VK2735 and advanced clinical subQ initiatives in the obesity treatment market, along with its novel amylin agonist, which is expected to start clinical trials later this year.

Viking Therapeutics, Inc. (NASDAQ:VKTX) stated that it is expecting topline data from its maintenance trial and the start of the Phase 3 program for oral VK2735 in the third quarter of 2026. The company additionally wrapped up its bioequivalence research and intends to add an autoinjector VK2735 format to the VANQUISH initiative during the first quarter of 2026.

Viking Therapeutics, Inc. (NASDAQ:VKTX) is a clinical-stage biopharmaceutical company developing treatments for metabolic and endocrine disorders, including obesity, NASH, and rare diseases such as X-linked adrenoleukodystrophy (X-ALD).

While we acknowledge the potential of VKTX to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than VKTX and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 11 of 11